Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123


Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells.

Chen YR, Liu MT, Chang YT, Wu CC, Hu CY, Chen JY.

J Virol. 2008 Aug;82(16):8124-37. doi: 10.1128/JVI.00430-08. Epub 2008 Jun 4.


Unique signaling properties of CTAR1 in LMP1-mediated transformation.

Mainou BA, Everly DN Jr, Raab-Traub N.

J Virol. 2007 Sep;81(18):9680-92. Epub 2007 Jul 11.


Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.

Hatton O, Lambert SL, Krams SM, Martinez OM.

PLoS One. 2012;7(8):e42610. doi: 10.1371/journal.pone.0042610. Epub 2012 Aug 3.


Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity.

Liu MT, Chang YT, Chen SC, Chuang YC, Chen YR, Lin CS, Chen JY.

Oncogene. 2005 Apr 14;24(16):2635-46.


EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.

Yang CF, Yang GD, Huang TJ, Li R, Chu QQ, Xu L, Wang MS, Cai MD, Zhong L, Wei HJ, Huang HB, Huang JL, Qian CN, Huang BJ.

Oncogene. 2016 Jun 30;35(26):3419-31. doi: 10.1038/onc.2015.402. Epub 2015 Nov 16.


Phosphorylation of FOXO3a by PI3K/Akt pathway in HK-2 renal proximal tubular epithelial cells exposed to cadmium.

Fujiki K, Inamura H, Matsuoka M.

Arch Toxicol. 2013 Dec;87(12):2119-27. doi: 10.1007/s00204-013-1077-6. Epub 2013 May 15.


Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.

Yang GD, Huang TJ, Peng LX, Yang CF, Liu RY, Huang HB, Chu QQ, Yang HJ, Huang JL, Zhu ZY, Qian CN, Huang BJ.

PLoS One. 2013 Oct 23;8(10):e78355. doi: 10.1371/journal.pone.0078355. eCollection 2013.


LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.

Sun J, Hu C, Zhu Y, Sun R, Fang Y, Fan Y, Xu F.

PLoS One. 2015 Aug 5;10(8):e0134896. doi: 10.1371/journal.pone.0134896. eCollection 2015.


Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway.

Li SS, Yang S, Wang S, Yang XM, Tang QL, Wang SH.

Oncol Rep. 2011 Dec;26(6):1573-9. doi: 10.3892/or.2011.1423. Epub 2011 Aug 17.


EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration.

Shair KH, Schnegg CI, Raab-Traub N.

Cancer Res. 2008 Sep 1;68(17):6997-7005. doi: 10.1158/0008-5472.CAN-08-1178.


Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch.

Shair KH, Schnegg CI, Raab-Traub N.

Cancer Res. 2009 Jul 15;69(14):5734-42. doi: 10.1158/0008-5472.CAN-09-0468. Epub 2009 Jul 7.


Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells.

Clavel S, Siffroi-Fernandez S, Coldefy AS, Boulukos K, Pisani DF, DĂ©rijard B.

Mol Cell Biol. 2010 Jan;30(2):470-80. doi: 10.1128/MCB.00666-09. Epub 2009 Nov 16.


Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation.

Meckes DG Jr, Menaker NF, Raab-Traub N.

J Virol. 2013 Feb;87(3):1301-11. doi: 10.1128/JVI.02519-12. Epub 2012 Nov 14.


Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.

Supplemental Content

Support Center